2014
DOI: 10.1016/j.neuroscience.2014.08.036
|View full text |Cite
|
Sign up to set email alerts
|

Brilliant Blue G improves cognition in an animal model of Alzheimer’s disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
57
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(58 citation statements)
references
References 32 publications
1
57
0
Order By: Relevance
“…Moreover, increased amyloid levels in mouse models of Alzheimer's disease results in decreased LTP and increased LTD (Palop and Mucke, 2010). In the mouse, infusion of beta amyloid into the hippocampus results in memory impairment, and when cultured neurons are treated with soluble beta amyloid, there are decreases in dendritic filopodia (Chen et al, 2014). …”
Section: Memory and Dendritic Spinesmentioning
confidence: 99%
“…Moreover, increased amyloid levels in mouse models of Alzheimer's disease results in decreased LTP and increased LTD (Palop and Mucke, 2010). In the mouse, infusion of beta amyloid into the hippocampus results in memory impairment, and when cultured neurons are treated with soluble beta amyloid, there are decreases in dendritic filopodia (Chen et al, 2014). …”
Section: Memory and Dendritic Spinesmentioning
confidence: 99%
“…In addition, the brain of infected mice had a diminished number of PrPres after the administration of BBG in vivo [73]. It is noteworthy that recently BBG was shown to prevent neuronal loss in mouse models and modulates amyloid- β aggregation and cytotoxicity in cell-based assays, suggesting a new therapy for AD [74, 75]. …”
Section: Brilliant Blue Dyes In Vivo Assaysmentioning
confidence: 99%
“…Such concepts, if put within the adequate context, would surely strengthen our knowledge about neuroscience and provide fruitful details to understand neurological functioning, develop therapies (based on both biochemistry and pharmacology [11][12][13]), build animal models of neurological disease [14,15] such as Alzheimer's disease [16,18] and Parkinson disease [19].…”
Section: Editorialmentioning
confidence: 99%
“…Importantly, biochemistry also describes metabotropic receptors of the nervous system, such as the G protein coupled receptors [8], that play important roles in both neurophysiology [9] and neuropharmacology [10]. Furthermore, biochemistry governs biological events related to field such as genetic (gene expression) and proteomics that are closely related to the well-functioning of the nervous system as well.Such concepts, if put within the adequate context, would surely strengthen our knowledge about neuroscience and provide fruitful details to understand neurological functioning, develop therapies (based on both biochemistry and pharmacology [11][12][13]), build animal models of neurological disease [14,15] such as Alzheimer's disease [16,18] and Parkinson disease [19]. …”
mentioning
confidence: 99%